NVNO Profile
enVVeno Medical Corporation, based in Irvine, California, is a pioneering medical device company specializing in advanced bioprosthetic tissue-based solutions aimed at improving the treatment of venous diseases. The company, which rebranded from Hancock Jaffe Laboratories, Inc. to enVVeno Medical Corporation in October 2021, was established in 1999 and has since focused on innovating and enhancing the standard of care in venous disease management.
At the forefront of enVVeno Medical's offerings is the VenoValve, a cutting-edge surgical implant designed to address severe cases of deep venous chronic insufficiency. This innovative device is strategically implanted into the femoral vein, functioning as a one-way valve to restore and regulate proper blood flow in the lower extremities. The VenoValve aims to alleviate symptoms and improve quality of life for patients suffering from chronic venous insufficiency, a condition marked by ineffective blood flow in the veins of the legs.
The VenoValve is a key component of enVVeno Medical's broader portfolio of bioprosthetic solutions. The company is dedicated to developing and commercializing advanced medical technologies that not only address critical venous disorders but also contribute to broader advancements in vascular care. enVVeno Medical Corporation’s research and development efforts are focused on creating effective and durable solutions that improve patient outcomes and set new standards in the field.
As it continues to advance its product pipeline and expand its market presence, enVVeno Medical Corporation remains committed to leveraging its expertise and innovation to drive progress in venous disease treatment. The company’s strategic focus on bioprosthetic tissue-based solutions reflects its mission to provide cutting-edge, high-quality medical devices that address significant healthcare needs and enhance patient care.
|
